BDA Scientific Advisors
The BDA Scientific Advisors consists of the following eminent members:

	Charles Swanton MRCP BSc FSB PhD - CR-UK/MRC Group leader of the Translational Cancer Therapeutics Laboratory at the CR-UK London Research Institute and Consultant medical oncologist at the Royal Marsden Hospital in the Breast and Drug Development Units
	Gilles Vassal, MD, PhD, Professor of Oncology, Direction of Clinical and Translational Research, Institut de Cancérologie Gustave-Roussy
	Professor Michel Marty,Director of Centre for Therapeutic Innovation in Oncology and Hematology in Saint Louis University Hospital (Paris, France)
	Prof. Angus Dalgleish, Oncology Division, St George's Medical School, London, UK
	Professor Chris McCabe, Unit of Health Economics, University of Leeds,UK,
	Prof Ian Ellis Professor of Cancer Pathology at the University Hospital, Nottingham, UK
	Prof Ashley Grossman, Professor of Neuroendocrinology at Bartholomew’s and the London School of Medicine
	Dr Steven Hirschfeld - Associate Director Clinical Research, National Institute of Child health and Human Development, Bethesda, USA
	Prof. Pat Price Director of Radiation Oncology, University of Manchester UK
	Prof. Bernie Fox Director of Oncology Research, Earle A. Chiles Research Institute, Portland, Oregon, USA
	Professor Giampietro Gasparini University Hospital, Rome, Italy
	Prof. Gustav Gaudernack Director of Oncology, University of Oslo, Norway
	Prof. Rolf Kiessling, Kalrolinska Institute, Stockholm, Sweden
	Prof. Klaus Pantel Director Institute for Tumour Biology, University of Hamburg, Germany
	Prof. Jamie Zwiebel, Chief for Biologics Evaluation, National Cancer Institute, Maryland, USA